PsyIndex TV

The CEO of Pure Extracts Corp.' Discusses Its Management Team

CEO Ben Nikolaevsky shares the background of Pure Extract's successful management team.

What does MagicMed have on the horizon for 2021?

CEO Dr. Joseph Tucker explains his view of the landscape in the psychedelics industry over the course of 2021.

MagicMed's CEO Discusses Health Canada's End of Life Order

Thought Leader Dr. Joseph Tucker discusses how the psychedelics industry will be impacted by the recent order by Health Canada.

Why Was MagicMed's Oversubscribed Raise So Successful?

Dr. Joseph Tucker, CEO of MagicMed Industries, shares insight into its very successful recent capital raise.

Is MagicMed Ready to Entertain Partners?

CEO Dr. Joseph Tucker explains MagicMed's readiness to engage in psilocybin and DMT business partnerships via its Psybrary.

What is MagicMed's Psybrary and How Can It be Utilized?

CEO Dr. Joseph Tucker explains their proprietary asset, the Psybrary.

How Does MagicMed De-risk the Business Model?

CEO Dr. Joseph Tucker discusses the unique approach his company has to the psychedelics industry.

What Does MagicMed Do Best?

CEO Dr. Joseph Tucker discusses MagicMed's business model.

Pure Extracts' Vision for the Future of Mushroom Extraction

Pure Extracts CEO Ben Nikolaevsky shares the company's plans to move to functional, then hallucinogenic mushrooms.

Pure Extracts' Biomass Extraction Business Model

CEO Ben Nikolaevsky shares the factors behind the 'perfect storm' in the extraction market that Pure Extracts is able to benefit from.